Design principles for inflammasome inhibition by pyrin-only-proteins
eLife · 22.01.2024 · 13
DOI: 10.7554/elife.81918 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 22.01.2024. Verfasst von Shuai Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, United States. Hauptthemen laut MEDLINE: Inflammasomes, Cytoskeleton. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Inflammasomes are filamentous signaling platforms essential for host defense against various intracellular calamities such as pathogen invasion and genotoxic stresses. However, dysregulated inflammasomes cause an array of human diseases including autoinflammatory disorders and cancer. It was recently identified that endogenous pyrin-only-proteins (POPs) regulate inflammasomes by directly inhibiting their filament assembly. Here, by combining Rosetta in silico, in vitro, and in cellulo methods, we investigate the target specificity and inhibition mechanisms of POPs. We find here that POP1 is ineffective in directly inhibiting the central inflammasome adaptor ASC. Instead, POP1 acts as a decoy and targets the assembly of upstream receptor pyrin-domain (PYD) filaments such as those of AIM2, IFI16, NLRP3, and NLRP6. Moreover, not only does POP2 directly suppress the nucleation of ASC, but it can also inhibit the elongation of receptor filaments. In addition to inhibiting the elongation of AIM2 and NLRP6 filaments, POP3 potently suppresses the nucleation of ASC. Our Rosetta analyses and biochemical experiments consistently suggest that a combination of favorable and unfavorable interactions between POPs and PYDs is necessary for effective recognition and inhibition. Together, we reveal the intrinsic target redundancy of POPs and their inhibitory mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, United States.
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, United States.
- Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, United States.
- Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, United States.
ORCID-Profile: Shuai Wu, Archit Garg, Michael A Chattergoon, Jungsan Sohn
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Science Foundation
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Wu, S., Garg, A., Mazanek, Z., Belotte, G., Zhou, J. J., Stallings, C. M., Lueck, J., Roland, A., Chattergoon, M. A., & Sohn, J. (2024). Design principles for inflammasome inhibition by pyrin-only-proteins. eLife, 13. https://doi.org/10.7554/elife.81918
Vancouver
Wu S, Garg A, Mazanek Z, Belotte G, Zhou JJ, Stallings CM, et al. Design principles for inflammasome inhibition by pyrin-only-proteins. eLife. 2024;13. doi:10.7554/elife.81918
BibTeX
@article{Wu2024,
author = {Wu, Shuai and Garg, Archit and Mazanek, Zachary and Belotte, Gretchen and Zhou, Jeffery J and Stallings, Christina M and Lueck, Jacob and Roland, Aubrey and Chattergoon, Michael A and Sohn, Jungsan},
title = {Design principles for inflammasome inhibition by pyrin-only-proteins},
journal = {eLife},
year = {2024},
volume = {13},
doi = {10.7554/elife.81918}
}
EUVIMED